Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > 007Dave

<< Previous

Bullboard Posts

Next >>

Comment by 007daveon Jan 01, 2021 11:25pm

139 Views

Post# 32208575

RE:RE: 007Dave

I agree on your sales take. Focusing on manufacturing first should be the priority. The potential for POC is huge going forward. Here in Canada starting Jan 7 every air passenger over 5 years old entering Canada must show a negative test to enter the country. Why the focus on FDA is beyond me. Why couldn't they licence the technology around the world. Imagine international travlers needing negative tests to travel. One hour accurate POC testing at airports seems like a no brainier.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program